Advertisement

Topics

Cambridge Cognition launches web-based testing using digital cognitive markers for virtual research

11:13 EST 7 Mar 2017 | Drug Discovery Today

The neuroscience digital health company Cambridge Cognition Holdings PLC, which develops and markets software products to improve brain health worldwide, today announced the launch of a new web-based testing product for conducting academic and clinical research studies online. Disorders affecting the brain are now the leading cause of disability and ill health worldwide. More than 1,000 disorders of the brain and central nervous system (CNS) result in huge costs and more hospitalisations and lost productivity than any other disease group, including heart disease and cancer.

Original Article: Cambridge Cognition launches web-based testing using digital cognitive markers for virtual research

NEXT ARTICLE

More From BioPortfolio on "Cambridge Cognition launches web-based testing using digital cognitive markers for virtual research"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...